30 results
8-K
EX-99.1
BIOCQ
Biocept Inc
14 Jul 22
Regulation FD Disclosure
6:07am
Strategy Expand CNSide Usage Among Thought-Leaders 1 Ø Generate further engagement, experience, and advocacy for CNSide with this small core of experts
DEFA14A
phdtxvtbx0hw44lg
27 Jun 22
Additional proxy soliciting materials
4:08pm
8-K
yd33o
27 Jun 22
Changes in Registrant's Certifying Accountant
4:06pm
8-K
EX-99.2
hcepss4stqubjn1gs
15 Apr 20
Securities Purchase Agreement
12:00am
8-K
EX-99.2
5q7d0ume 0sdcv
5 Mar 20
Securities Purchase Agreement
4:45pm
8-K
EX-99.2
h074e9
3 Mar 20
Securities Purchase Agreement
4:40pm
8-K
EX-10.2
m1wk1tbw
18 Mar 19
Biocept Announces Pricing of $8.2 Million Registered Direct Offering
12:00am
424B5
zd5 226jb3tq
15 Mar 19
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.2
gdd zo2et7
18 Jan 19
Biocept Announces Pricing of $2.2 Million Registered Direct Offering
4:51pm
424B5
bm6hbdgislw4l1 au
18 Jan 19
Prospectus supplement for primary offering
4:41pm